does semaglutide cause birth defects Can Infertility? Evidence and Guidance Ozempic (semaglutide) and vaginal health

The market also sees significant opportunities for expanding the application of GLP-1 receptor agonists beyond diabetes, with emerging research exploring their role in treating heart failure, non-alcoholic steatohepatitis (NASH), and other chronic conditions

Egypt Poult Sci

FDA Oral Wegovy Approval: What the December 22, 2025 Decision Means The FDA's approval of the Wegovy pill represents the first oral GLP-1 medication cleared specifically for weight loss

The liver from Gclc L-KO mice showed rapid depletion of Gclc mRNA and progressive loss of GCLC protein and GSH levels (Fig

FDA-approved GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), exenatide (Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist